Clinical Trials Directory

Trials / Unknown

UnknownNCT03922698

Potential Impact of Neuroimmune and Autophagic Alterations on the Progression and Severity of Human Atherosclerotic Process

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Neuromed IRCCS · Academic / Other
Sex
All
Age
45 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The hypothesis of this study is that neural regulations of the atherosclerotic plaque, identified in the murine model of atherosclerosis, could also exist in human pathology. The dysregulation status of the autonomic nervous system is typical of several cardiovascular diseases, but the role it exerts in the modulation of important mechanisms at the basis of the atherosclerotic process progression has not been investigated yet. The main aim of this study will be to investigate, in the atherosclerotic plaque, the alterations of inflammatory and immune processes, the neural modulations and the presence of dysregulations of the autophagic process. The investigators will also associate the potential presence of neural modulations of the plaque to its stability/instability, from a clinical-translational point of view. Finally, the investigators aim at providing a solid basis for the development of novel therapeutic strategies, which could reduce the elevated health and welfare costs for the clinical management of cardiovascular pathologies such as atherosclerosis.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionsNo interventions - observational study

Timeline

Start date
2019-06-01
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2019-04-22
Last updated
2022-04-11

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03922698. Inclusion in this directory is not an endorsement.